迈威生物-U
(688062)
| 流通市值：51.32亿 | | | 总市值：99.58亿 |
| 流通股本：2.30亿 | | | 总股本：4.47亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 312,641,623.7 | 127,597,218.83 | 662,515,554.62 | 565,838,248.14 |
| 营业总成本 | 824,538,887.31 | 356,747,236.67 | 1,634,418,367.37 | 1,164,855,191.83 |
| 其他经营收益 | | | | |
| 营业利润 | -516,868,789.62 | -238,881,544.3 | -955,317,716 | -582,936,935.76 |
| 利润总额 | -523,815,199.66 | -240,151,217.82 | -956,393,708.06 | -582,677,606.59 |
| 净利润 | -524,204,538.99 | -243,042,847.72 | -972,257,776.24 | -599,596,769.92 |
| 每股收益 | | | | |
| 其他综合收益 | -1,934,011.07 | -759,615.5 | -626,593.53 | 2,664.16 |
| 综合收益总额 | -526,138,550.06 | -243,802,463.22 | -972,884,369.77 | -599,594,105.76 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,876,235,897.51 | 2,112,716,986.29 | 2,038,604,874.89 | 1,945,024,390.54 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,418,749,681.83 | 2,455,630,290.75 | 2,517,237,523.1 | 2,582,064,872.56 |
| 资产总计 | 5,294,985,579.34 | 4,568,347,277.04 | 4,555,842,397.99 | 4,527,089,263.1 |
| 流动负债: | | | | |
| 流动负债合计 | 2,303,319,511.17 | 2,411,812,766.24 | 2,258,603,546.69 | 2,158,018,752.66 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,937,182,477.44 | 1,867,323,589.21 | 1,764,236,022.82 | 1,423,488,042.1 |
| 负债合计 | 4,240,501,988.61 | 4,279,136,355.45 | 4,022,839,569.51 | 3,581,506,794.76 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 873,485,318.54 | 106,815,052.75 | 349,507,699.53 | 761,099,851.75 |
| 股东权益合计 | 1,054,483,590.73 | 289,210,921.59 | 533,002,828.48 | 945,582,468.34 |
| 负债和股东权益合计 | 5,294,985,579.34 | 4,568,347,277.04 | 4,555,842,397.99 | 4,527,089,263.1 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 312,456,732.7 | 127,734,377.54 | 995,140,217.2 | 862,766,573.45 |
| 经营活动现金流出小计 | 821,395,170.43 | 361,897,548.66 | 1,285,363,383.62 | 965,798,043.04 |
| 经营活动产生的现金流量净额 | -508,938,437.73 | -234,163,171.12 | -290,223,166.42 | -103,031,469.59 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 124,434,525.03 | 7,407,853.07 | 230,227,288.71 | 182,405,570.12 |
| 投资活动现金流出小计 | 265,169,020.7 | 106,963,398.47 | 429,542,270.14 | 383,466,693.34 |
| 投资活动产生的现金流量净额 | -140,734,495.67 | -99,555,545.4 | -199,314,981.43 | -201,061,123.22 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 2,375,488,398.12 | 924,980,000 | 3,265,810,000 | 1,685,840,000 |
| 筹资活动现金流出小计 | 940,987,027.65 | 631,554,858.05 | 2,473,885,150.06 | 1,168,592,549.64 |
| 筹资活动产生的现金流量净额 | 1,434,501,370.47 | 293,425,141.95 | 791,924,849.94 | 517,247,450.36 |
| 汇率变动对现金及现金等价物的影响 | -17,235,653.31 | -2,610,067.84 | -3,613,540.5 | -1,291,825.48 |
| 现金及现金等价物净增加额 | 767,592,783.76 | -42,903,642.41 | 298,773,161.59 | 211,863,032.07 |
| 期末现金及现金等价物余额 | 2,293,932,110.58 | 1,483,435,684.41 | 1,526,339,326.82 | 1,439,429,197.3 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 767,592,783.76 | - | 298,773,161.59 | - |
最新报告期：2026-10-08| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 西部证券 | 李梦园,杨天笑 | -1.85 | -1.15 | -0.33 | 2026-10-08 |
| 华源证券 | 刘闯 | -1.78 | -1.16 | -0.19 | 2026-09-21 |
| 中邮证券 | 盛丽华 | -1.84 | -1.12 | 0.08 | 2026-09-10 |
| 中国银河 | 程培,闫晓松 | -2.08 | -1.26 | 0.15 | 2026-09-03 |
| 中信建投 | 袁清慧 | -2.07 | -1.42 | -0.49 | 2026-09-02 |